Compare SLNG & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNG | MBOT |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 126.9M |
| IPO Year | 2019 | 2000 |
| Metric | SLNG | MBOT |
|---|---|---|
| Price | $5.79 | $1.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $10.00 | $7.50 |
| AVG Volume (30 Days) | 50.2K | ★ 735.0K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2400.00 | 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $68,245,000.00 | $116,887.00 |
| Revenue This Year | $8.66 | N/A |
| Revenue Next Year | $14.31 | $119.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.21 | $1.44 |
| 52 Week High | $7.07 | $3.74 |
| Indicator | SLNG | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 43.29 |
| Support Level | $3.45 | $1.44 |
| Resistance Level | $6.14 | $2.21 |
| Average True Range (ATR) | 0.52 | 0.06 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 19.23 | 50.00 |
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.